It was showed that ITGA5 and ITGB3 are expressed in glioma vessels and tumor cells and the gene expression is significantly associated with the malignancy grade of the tumor and poor patient prognosis [34,46]. This evidence concerns the gene ITGB3 and central nervous system cancer.